Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 
Market Update : 
Amgen Falls 4% on Cancer Drug
Author: Elena Todorova
123jump.com
Last Update: 10:08 AM EDT March 23 2007


Email article | Print article

Wall Street opened nearly flat on Friday, with investors waiting for the release of February existing home sales. In corporate news, Amgen fell 4.2% after the company halted a trail of colon cancer drug Vectibix. ImClone Systems, which makes Erbitux, a competitor drug to Vectibix, jumped 15%. DaimlerChrysler rose 4.1% amid reports the automaker would sell its Chrysler unit.

 

 

 
 Email article:
 
  To Email:
  From Email :
 
   
More: Market Update Archive

 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved